ArriVent BioPharma, Inc. (AVBP)
NASDAQ: AVBP · IEX Real-Time Price · USD
18.41
+0.26 (1.43%)
At close: Jul 2, 2024, 4:00 PM
18.43
+0.02 (0.11%)
After-hours: Jul 2, 2024, 4:59 PM EDT
ArriVent BioPharma Market Cap
ArriVent BioPharma has a market cap or net worth of $616.62 million as of July 2, 2024.
Market Cap
616.62M
Enterprise Value
299.51M
1-Year Change
n/a
Ranking
Category
Stock Price
$18.41
Market Cap Chart
Since the IPO on January 26, 2024, ArriVent BioPharma's market cap has increased from $575.22M to $616.62M, an increase of 7.20%. That is a compound annual growth rate of 17.54%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 1, 2024 | 607.90M | 5.68% |
| Jan 26, 2024 | 575.22M | - |
View and export this data all the way back to 2024.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Wave Life Sciences | 639.32M |
| Prime Medicine | 633.76M |
| Pulse Biosciences | 630.12M |
| UroGen Pharma | 622.71M |
| GH Research | 619.65M |
| Travere Therapeutics | 615.88M |
| Scholar Rock Holding | 608.52M |
| Humacyte | 608.52M |